MediciNova 8-K 2005
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 14, 2005
(Exact name of registrant as specified in its charter)
4350 La Jolla Village Drive, Suite 950
San Diego, CA 92122
(Address of principal executive offices) (Zip Code)
Registrants telephone number, including area code: (858) 373-1500
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
On November 15, 2005 (Japanese Standard Time), MediciNova, Inc. (hereinafter the Company, we, or us) filed with the Osaka Securities Exchange (the OSE) a Japanese report referred to as Kessan Tanshin, which contained, among other things, our financial results for the quarter ended September 30, 2005 (the Tanshin).
The Tanshin is substantially the same as the Companys Financial Report on Form 10-Q (the 10-Q) for the quarter ended September 30, 2005 except the following supplemental information is provided:
First, we state that the reason behind the increase of prepaid expenses and other current assets by $1.4 million during the nine months ended September 30, 2005 from $0.5 million at December 31, 2004 to $1.9 million at September 30, 2005 was due to:
Second, we state that the reason behind the decrease of other assets by $2.2 million during the nine months ended September 30, 2005 from $2.2 million at December 31, 2004 to $0 at September 30, 2005 is because this amount was deducted from stockholders equity when the costs associated with our initial public offering (the IPO) were deducted from stockholders equity at the completion of the IPO during the period.
Finally, we state that the reason behind the decrease of total liabilities by $41.1 million during the nine months ended September 30, 2005 from $46.1 million at December 31, 2004 to $5.0 million at September 30, 2005 is because the redemption right of Series C Preferred stock was eliminated upon the automatic conversion of all of the Companys preferred stock into common stock upon the completion of the IPO during the period.
The information in this Form 8-K is being furnished and shall not be deemed filed for the purposes of Section 18 of the Securities Exchange Act of 1934, or otherwise subject to the liability of that section. The information in this Form 8-K shall not be incorporated by reference into any registration statement or filing of the Company, except as shall be expressly set forth by specific reference in such a filing.
This report may contain forward-looking statements as defined by the Securities and Exchange Commission (the SEC). All statements, other than statements of historical facts, included in this report that address activities, events or developments that the Company expects, believes or anticipates will or may occur in the future are forward-looking statements. These statements are based on certain assumptions made by the Company based on managements experience and perception of historical trends, current conditions, expected future developments and other factors it believes are appropriate in the circumstances. Such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause the Companys actual results to differ materially from those implied or expressed by the forward-looking statements. These forward-looking statements speak only as of the date hereof. For a discussion of factors that may cause results to differ, please see the Companys SEC reports, including its Financial Report on Form 10-Q for the quarter ended September 30, 2005 and the Companys Prospectus Supplement filed with the SEC on November 14, 2005.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.